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In a November/December 2010 arti-
cle published in the influential journal
Foreign Affairs, United States Secretary of
State Hilary Rodham Clinton articulated
a new vision for American diplomacy and
development through the strengthening
of what she terms ‘‘civilian power’’ [1].
Stated briefly, the new doctrine calls for
the creation of a new cadre of civilian
experts who could jointly pursue diploma-
cy and international development for pur-
poses of solving global challenges related
to health, agriculture and food insecurity,
environmental degradation, drugs and or-
ganized crime, energy, and climate change
[1]. Through joint programs between the
US Department of State and its United
States Agency for International Develop-
ment (USAID) and the additional hiring of
more than 1,000 Foreign and Civil Service
Officers in each organization, and reflect-
ing the results of a new Quadrennial Di-
plomacy and Development Review, in the
coming years the State Department and
USAID would now work more closely to
enhance global development in the con-
text of diplomacy. The world’s conflict
and post-conflict zones and fragile states
would represent key targets for interna-
tional development efforts [1]. In this new
doctrine, Secretary Clinton proposes that
together the State Department and USAID
would establish a premier global civilian
service for responding to complex diplo-
matic and development challenges [1].
Achieving such an ambitious goal would
also mandate that USAID look beyond its
walls to embrace business, philanthropist,
and citizen groups, with dual emphases on
partnering with some of the large emerging
market economies (EMEs), i.e., China,
India, Indonesia, Nigeria, Pakistan, Russia,
and South Africa, for joint problem solving,
and harnessing selected technologies, such
as rapidly expanding cell phone access, for
establishing a sustainable and lasting im-
pact [1].
The control and elimination of the
world’s major neglected tropical diseases
(NTDs) represents a substantive global
health and economic challenge, yet one
that with a well-coordinated assault in the
mode as proposed by Secretary Clinton
could become the first major victory for
civilian power. The NTDs are the most
common infections of the world’s poor,
and almost all of the ‘‘bottom billion,’’ i.e.,
the 1.4 billion people, who live on no
money, are infected with one or more
NTD [2,3]. In addition to causing a level
of global disability that compares with that
of HIV/AIDS or malaria, NTDs actually
cause poverty through their ability to
impair child development, pregnancy out-
comes, and agricultural productivity and
food security [3]. These diseases also de-
stabilize communities and promote civil
and international conflicts [4].
There are a number of reasons why
taking on the NTDs wouldbe a worthy early
first test for civilian power. It is now possible
to control or in some cases eliminate one or
more of the seven most common NTDs,
i.e., ascariasis, hookworm infection, trichu-
riasis, schistosomiasis, lymphatic filariasis,
onchocerciasis, and trachoma, through mass
drug administration using a ‘‘rapid impact
package’’ of drugs that are either donated by
the major pharmaceutical companies or
available as low cost generics and admin-
istered as a part of national control
programs [2,3,5]. Mass drug administra-
tion for NTDs through rapid impact is
one of the lowest cost and cost-efficient
mechanisms for both improving maternal
child health [6] and lifting the bottom
billion out of poverty [3]. The United
States government (USG), through its
Global Health Initiative (GHI) and
USAID’s NTD Program, is already pro-
viding financial support for 12 national
NTD programs, more than all other
countries combined, with additional pro-
grams scheduled in the coming years [7].
With assistance from the Department of
State, the USAID NTD Program can now
reach out to the major EMEs listed above
in order to join forces on global NTD
control efforts. A USAID–EMEs link makes
sense on two fronts: First, it has already
been noted that Nigeria has the largest
number people infected with the seven
NTDs among the sub-Saharan African
countries, while South Africa suffers from
high rates of some of the soil-transmitted
helminth infections and schistosomiasis [8].
Similarly, China, India, Indonesia, and
Pakistan have the largest number of asca-
riasis, trichuriasis, hookworm, lymphatic
filariasis, and trachoma cases, as well as
other NTDs such as leprosy in Asia [9,10].
Working jointly with experts from USAID
and other branches of the USG and GHI,
a focused effort on NTDs in the EMEs
could ultimately double the total number of
at-risk populations receiving rapid impact
packages. In addition, China invests billions
of dollars in sub-Saharan Africa annually
and could also make substantial contributions
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possibly doubling yet again the USAID
contribution [11]. In time, USAID and the
EMEs could combine to target most of the
people at risk in Africa and Asia from
NTDs with rapid impact packages, thereby
helping to affect lymphatic filariasis, on-
chocerciasis, and trachoma eliminations
and advancing soil-transmitted helminth
infection and schistosomiasis control in
many of these countries.
Strengthening fragile and failing states
is a key element of Secretary Clinton’s
doctrine for civilian power [1]. Some of
the highest rates of NTDs occur in conflict
and post-conflict countries [4], and in frag-
ile nations such as Mali, Mauritania, Niger,
Pakistan, Somalia, and Yemen where, ac-
cording to Secretary Clinton [1], Al Qaeda
operates [12]. Because the NTDs destabilize
these communities and also represent im-
portant impediments to human rights [4,
13], NTD control should comprise an
essential element of civilian power for the
reinvention of American diplomacy and
development. The business and philan-
thropic communities can also be engaged
in global NTD efforts through the establish-
ment of a new private fund (End Neglected
Diseases, END) established jointly by Lega-
tum and Geneva Global [14], and support-
ed by the non-profit Global Network for
Neglected Tropical Diseases, while simulta-
neously continuing to work jointly with the
major pharmaceutical companies for ensur-
ing ongoing commitments for existing NTD
drug donations [5], as well as expanding
commitments to provide urgently needed
essential medicines such as praziquantel [15].
USAID could also engage EME and
private partners in international research
and development efforts to generate and
produce new NTD control tools such as
drugs, vaccines, and diagnostics [13]. Such
products are sometimes referred to as anti-
poverty technologies [13,16]. Currently
neither USAID nor GHI provide signifi-
cant support for NTD antipoverty tech-
nologies, but even a 1%–2% allocation of
the total GHI budget could mobilize an
estimated US$100–200 million annually
for this purpose [16]. The EME countries,
but especially Brazil and India, are actively
pursuing the development and testing of
new NTD products [17]. The USG and
major US research universities are failing
to take advantage of an incredible oppor-
tunity to expand joint research and devel-
opment activities with the EMEs, beyond
the current product development partner-
ship activities and the Tropical Medicine
Research Centers supported by the
National Institutes of Health [16], by not
incorporating NTD product development
into a larger program of science and
technology diplomacy [18]. Vaccine di-
plomacy also represents an exciting op-
portunity to jointly pursue antipoverty vac-
cine development with some of the large
middle-income countries that comprise the
Organisation of the Islamic Conference
(OIC), i.e., technologically proficient na-
tions such as Indonesia, Iran, and Pakistan
[18]. Such activities could link with the
major multinational pharmaceutical com-
panies and would be consistent with Sec-
retary Clinton’s calls for expanded use of
technology for diplomacy and development
[1]. An expanded USG initiative in this
context could also lead to greater global
investment in NTD research just as the
2009 Group of Eight (G8) meeting in Italy
led the US to secure a US$20 billion inter-
national commitment for food security [1].
A global assault on NTDs both through
expanded deployment of rapid impact
packages and research and development
for new drugs, vaccines, and diagnostics
would represent a modern day Marshall
Plan for the world’s developing countries.
Conducted jointly with the EMEs and
leading OIC countries, the global NTD
assault would maximize civilian power in
order to achieve the diplomatic and de-
velopment goals of the USG.
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